Simcere Given SFDA Approval of Anti-Nausea Drug

Simcere Pharmaceutical Group (先声药业) reported that its China subsidiary, Simcere Dongyuan Pharmaceutical Co., was granted SFDA approval to manufacture and market Palonosetron material and injections. Palonosetron is given to prevent the nausea and vomiting side effects of chemotherapy. Simcere, which focuses on branded generics, already markets four other drugs that treat cancer. More details... Stock Symbol: (NYSE: SCR)